Literature DB >> 33408611

Subjective Sleep Quality in Amnestic Mild Cognitive Impairment Elderly and Its Possible Relationship With Plasma Amyloid-β.

Yajing Liu1, Lushi Chen1, Shuyun Huang1, Chengguo Zhang1, Zeping Lv2, Jiali Luo1, Pan Shang1, Yukai Wang1, Haiqun Xie1.   

Abstract

STUDY
OBJECTIVES: To investigate the extent to which sleep quality associated with plasma Aβ levels in amnestic mild cognitive impairment (aMCI) elderly.
METHODS: A total of 172 cognitively normal (NC) elderly and 133 aMCI elderly were included in this study. For the evaluation of sleep quality, the Pittsburgh Sleep Quality Index (PSQI) was used. Levels of plasma Aβ were determined by the sandwich enzyme-linked immunosorbent assay technique. Multivariable linear regression analysis was applied to evaluate associations between sleep quality and plasma Aβ levels after adjusting potential confounders.
RESULTS: Compared to NC subjects, participants with aMCI had a higher global PSQI score (8.72 ± 3.87 vs. 7.10 ± 3.07, p < 0.001). The global PSQI score was positively associated with plasma Aβ42 level in the aMCI group (β = 0.063, 95% CI 0.001-0.125, and p = 0.049) but not in the NC group (p > 0.05). Additionally, a higher global PSQI score was associated with a higher plasma Aβ42/Aβ40 ratio in both NC (β = 0.010, 95% CI 0.003-0.016, and p = 0.003) and aMCI groups (β = 0.012, 95% CI 0.005-0.018, and p < 0.001). The association between global PSQI score and plasma Aβ42/Aβ40 ratio was stronger in individuals with aMCI relative to the NC subjects (β = 0.076 vs. 0.030, p for interaction = 0.023).
CONCLUSION: Poor sleep quality was associated with plasma Aβ42 and Aβ42/Aβ40 ratio, with a stronger effect among individuals with aMCI. A better understanding of the role of sleep in plasma Aβ levels in aMCI patients could lead to effective sleep-based intervention against the risk of Alzheimer's disease.
Copyright © 2020 Liu, Chen, Huang, Zhang, Lv, Luo, Shang, Wang and Xie.

Entities:  

Keywords:  Alzheimer’s disease; Pittsburgh Sleep Quality Index; amnestic mild cognitive impairment; plasma amyloid-β; sleep quality

Year:  2020        PMID: 33408611      PMCID: PMC7779602          DOI: 10.3389/fnins.2020.611432

Source DB:  PubMed          Journal:  Front Neurosci        ISSN: 1662-453X            Impact factor:   4.677


  37 in total

1.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women.

Authors:  Kristine Yaffe; Alison M Laffan; Stephanie Litwack Harrison; Susan Redline; Adam P Spira; Kristine E Ensrud; Sonia Ancoli-Israel; Katie L Stone
Journal:  JAMA       Date:  2011-08-10       Impact factor: 56.272

3.  Disruption of circadian clocks has ramifications for metabolism, brain, and behavior.

Authors:  Ilia N Karatsoreos; Sarah Bhagat; Erik B Bloss; John H Morrison; Bruce S McEwen
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

4.  The overnight reduction of amyloid β 1-42 plasma levels is diminished by the extent of sleep fragmentation, sAPP-β, and APOE ε4 in psychiatrists on call.

Authors:  Timo Grimmer; Theresa Laub; Alexander Hapfelmeier; Tamara Eisele; Bastian Fatke; Patricia Hölzle; Sandra Lüscher; Anna-Mareike Parchmann; Michael Rentrop; Dirk Schwerthöffer; Felix Müller-Sarnowski; Marion Ortner; Oliver Goldhardt; Alexander Kurz; Hans Förstl; Panagiotis Alexopoulos
Journal:  Alzheimers Dement       Date:  2020-04-08       Impact factor: 21.566

5.  A longitudinal study of polysomnographic variables in patients with mild cognitive impairment converting to Alzheimer's disease.

Authors:  Luca Carnicelli; Michelangelo Maestri; Elisa Di Coscio; Gloria Tognoni; Monica Fabbrini; Alessandro Schirru; Filippo S Giorgi; Gabriele Siciliano; Ubaldo Bonuccelli; Enrica Bonanni
Journal:  J Sleep Res       Date:  2019-02-06       Impact factor: 3.981

6.  Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle.

Authors:  Jae-Eun Kang; Miranda M Lim; Randall J Bateman; James J Lee; Liam P Smyth; John R Cirrito; Nobuhiro Fujiki; Seiji Nishino; David M Holtzman
Journal:  Science       Date:  2009-09-24       Impact factor: 47.728

7.  Plasma Aβ but not tau is related to brain PiB retention in early Alzheimer's disease.

Authors:  Kai-Yuan Tzen; Shieh-Yueh Yang; Ta-Fu Chen; Ting-Wen Cheng; Herng-Er Horng; Hsiang-Ping Wen; Ya-Yao Huang; Chyng-Yann Shiue; Ming-Jang Chiu
Journal:  ACS Chem Neurosci       Date:  2014-08-13       Impact factor: 4.418

8.  Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers.

Authors:  Olivier Hanon; Jean-Sébastien Vidal; Sylvain Lehmann; Stéphanie Bombois; Bernadette Allinquant; Jean-Marc Tréluyer; Patrick Gelé; Christine Delmaire; Fredéric Blanc; Jean-François Mangin; Luc Buée; Jacques Touchon; Jacques Hugon; Bruno Vellas; Evelyne Galbrun; Athanase Benetos; Gilles Berrut; Elèna Paillaud; David Wallon; Giovanni Castelnovo; Lisette Volpe-Gillot; Marc Paccalin; Philippe-Henri Robert; Olivier Godefroy; Thierry Dantoine; Vincent Camus; Joël Belmin; Pierre Vandel; Jean-Luc Novella; Emmanuelle Duron; Anne-Sophie Rigaud; Suzanna Schraen-Maschke; Audrey Gabelle
Journal:  Alzheimers Dement       Date:  2018-02-17       Impact factor: 21.566

9.  The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.

Authors:  D J Buysse; C F Reynolds; T H Monk; S R Berman; D J Kupfer
Journal:  Psychiatry Res       Date:  1989-05       Impact factor: 3.222

10.  Sleep drives metabolite clearance from the adult brain.

Authors:  Lulu Xie; Hongyi Kang; Qiwu Xu; Michael J Chen; Yonghong Liao; Meenakshisundaram Thiyagarajan; John O'Donnell; Daniel J Christensen; Charles Nicholson; Jeffrey J Iliff; Takahiro Takano; Rashid Deane; Maiken Nedergaard
Journal:  Science       Date:  2013-10-18       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.